World Journal of Neuroscience
Vol.9 No.3(2019), Paper ID 93873, 25
pages
DOI:10.4236/wjns.2019.93008
A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Long-Acting Injectable Formulation of Vanoxerine (Vanoxerine Consta 394.2 mg) for Cocaine Relapse Prevention
Sead Kadric, Hanns Mohler, Olli Kallioniemi, Karl Heinz Altmann
Division for academic research AURUM Group, Ludgate Hill, London, UK
Division for academic research AURUM Group, Ludgate Hill, London, UK
Division for academic research AURUM Group, Ludgate Hill, London, UK
Division for academic research AURUM Group, Ludgate Hill, London, UK
Copyright © 2019 Sead Kadric, Hanns Mohler, Olli Kallioniemi, Karl Heinz Altmann et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Kadric, S. , Mohler, H. , Kallioniemi, O. and Altmann, K. (2019) A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Long-Acting Injectable Formulation of Vanoxerine (Vanoxerine Consta 394.2 mg) for Cocaine Relapse Prevention.
World Journal of Neuroscience,
9, 113-137. doi:
10.4236/wjns.2019.93008.